Vol 7 (September 30, 2022): Annals of Blood

Review Article 
A narrative review: the role of DOCK2 in immune-related diseases, hematopoietic or vascular diseases and solid tumor
Yuanyuan Chen, Muping Di, Yan Tang, Jianchuan Xia
Annals of Blood  
2022;
7:
32  
Review Article 
A narrative review of PD-1 and autoimmune diseases
Yanan Deng, Feng Huang, Jie Wang
Annals of Blood  
2022;
7:
31  
Review Article 
The application of COVID-19 convalescent plasma in clinical treatment
Yan Liu, Aiping Liu, Rong Wang, Changfeng Shao, Ping Li, Qiang Ju, Shumin Chen, Peng Zong, Licun Wang, Haiyan Wang
Annals of Blood  
2022;
7:
29  
Review Article 
THERAFLEX ultraviolet C (UVC)-based pathogen reduction technology for bacterial inactivation in blood components: advantages and limitations
Torsten J. Schulze, Ute Gravemann, Axel Seltsam
Annals of Blood  
2022;
7:
28  
Original Article 
An analysis of the factors associated with successful re-entry of blood donors
Danrong Yang, Xiaohong Li, Weifei Qin, Huayou Dai, Junhong Yang, Zhanpeng Luo, Fang Wang, Wenjie Hu, Pei Yang, Hengying Duan, Xia Huang
Annals of Blood  
2022;
7:
27  
Original Article 
Transfusion transmitted bacterial infections (TTBI) involving contaminated platelet concentrates: residual risk despite intervention strategies
Wieke Freudenburg-de Graaf, Saskia Spelmink, Josephine Heijnen, Dirk de Korte
Annals of Blood  
2022;
7:
26  
Editorial 
Convalescent plasma special series
Massimo Franchini
Annals of Blood  
2022;
7:
25  
Editorial 
Bacterial contamination of platelet components
Sandra Ramirez-Arcos, Carl McDonald; ISBT Transfusion Transmitted Infectious Diseases Working Party Bacteria Subgroup
Annals of Blood  
2022;
7:
24